| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 09/18/2003 | US20030175245 Replication deficient adenoviral TNF vector |
| 09/18/2003 | US20030175244 Capsid-modified recombinant adenovirus and methods of use |
| 09/18/2003 | US20030175243 Blocking receptor binding; gene therapy; gastrin releasing peptide |
| 09/18/2003 | CA2478371A1 Compositions and methods for generating an immune response |
| 09/18/2003 | CA2475165A1 Recovery of viruses |
| 09/17/2003 | EP1343897A2 Purified active hcv ns2/3 protease |
| 09/17/2003 | EP1343896A1 Small acid-soluble spore protein and uses thereof |
| 09/17/2003 | EP1187530B1 Improved storage and maintenance of blood products including red blood cells and platelets |
| 09/17/2003 | CN1443243A 修饰的病毒 Modified viruses |
| 09/17/2003 | CN1443076A Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant avipoxvirus vaccine |
| 09/17/2003 | CN1442479A Mammalian engineering cell line for production of hantan virus granules |
| 09/17/2003 | CN1121496C Method for culturing anchorage dependent animal cell to produce virus by using magnetic stable fluidized bed |
| 09/16/2003 | US6620913 Polypeptides of a novel hantavirus |
| 09/16/2003 | US6620618 Containing DNA expressing the adenovirus protease; for gene transfer purposes, vaccines |
| 09/16/2003 | US6620595 Retroviral vectors comprising an enhanced 3′ transcription termination structure |
| 09/12/2003 | WO2003074711A1 Expression cassette for persistence of expression of a gene of interest in muscle cells |
| 09/12/2003 | WO2003074552A1 An infectious bursal disease virus variant |
| 09/12/2003 | WO2003073918A2 Prevention of recurrence and metastasis of cancer |
| 09/12/2003 | WO2003011893A3 Immunologically significant herpes simplex virus antigens and methods for using same |
| 09/12/2003 | WO2002044204A3 Cell-free assembly of lentiviral capsids |
| 09/12/2003 | CA2477874A1 Expression cassette for persistence of expression of a gene of interest in muscle cells |
| 09/12/2003 | CA2476724A1 Prevention of recurrence and metastasis of cancer |
| 09/11/2003 | US20030172397 Papaya ringspot virus genes |
| 09/11/2003 | US20030171541 Selective binding agents, vectors, host cells, and methods for producing GPCR polypeptides; diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with GPCR polypeptides |
| 09/11/2003 | US20030171336 A packaging cell line capable of complementing recombinant adenoviruses based on serotypes from subgroup B, preferably adenovirus type 35. The cell line is preferably derived from primary, diploid human cells transformed by adenovirus E1 |
| 09/11/2003 | US20030170899 Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus |
| 09/11/2003 | US20030170896 Adeno-asociated virus (AAV) vectors that are capable of being transferred between cells; used to support comercially significant levels or rAAV particles without infectious helper virus or other harmful by-products |
| 09/11/2003 | US20030170885 Used for the transfer and expression of exogenous nucleotide sequences in a host cell or organism; gene therapy |
| 09/11/2003 | US20030170871 Alphavirus-based vectors for persistent infection |
| 09/11/2003 | US20030170870 For broad use in therapy and prevention including antisense agents and vaccines |
| 09/11/2003 | US20030170807 Expression vectors; use in identifying compound that modulates receptor activated calcium mobilization |
| 09/11/2003 | US20030170710 Quantitative analysis of adenovirus; gene therapy |
| 09/11/2003 | US20030170658 Genetic engineered retroviruses; detecting antigen, antibody complex; medical diagnosis |
| 09/11/2003 | US20030170614 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
| 09/11/2003 | US20030170272 EIA vaccine and diagnostic |
| 09/11/2003 | US20030170271 Chimeric papillomavirus-like particles |
| 09/11/2003 | US20030170270 Nucleic acid encoding an infectious, nonpathogenic PCV1, which contains an immunogenic open reading frame gene of a pathogenic PCV2 in place of an ORF gene of the PCV1 nucleic acid molecule. |
| 09/11/2003 | US20030170269 Vaccine for mystery swine disease and method for diagnosis thereof |
| 09/11/2003 | US20030170266 Complex of a paramyxovirus-derived negative-strand single-stranded RNA modified not to express an envelope protein of paramyxoviruses, and proteins that bind to it |
| 09/11/2003 | US20030170211 For delivering alphavirus replicon DNA into an animal or animal cells with the replicon encoding one or more heterologous genes to be expressed in the animal or the animal cells |
| 09/10/2003 | EP1341496A2 COMPOSITIONS AND METHODS FOR REDUCING THE AMOUNT OF i SALMONELLA /i IN LIVESTOCK |
| 09/10/2003 | CN1441842A Manipulation of negative stranded RNA viruses by rearrangement of their genes and uses thereof |
| 09/09/2003 | US6617157 Using inactivating agent of given formula to inactivate any virus contained in donor blood, blood products, or other biological compositions; can also use in vaccines |
| 09/09/2003 | US6617101 Lipophilic quenching of viral inactivating agents |
| 09/09/2003 | US6616931 Containing sugar; phosphate; carboxylate; recombinant human serum albumin or a nonionic surfactant |
| 09/04/2003 | WO2003073062A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 09/04/2003 | WO2003072725A2 Recombinant negative strand virus rna expression systems and vaccines |
| 09/04/2003 | WO2003072722A2 IMMUNOGENIC AVIAN HBc CHIMER PARTICLES HAVING ENHANCED STABILITY |
| 09/04/2003 | WO2003072720A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 09/04/2003 | WO2003072719A2 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences |
| 09/04/2003 | WO2003072716A2 Sequence analysis of the tetravalent rotavirus vaccine |
| 09/04/2003 | WO2003020958A3 Campylobacter typing |
| 09/04/2003 | WO2002032943A9 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 09/04/2003 | WO2002020769A9 Human and mouse targeting peptides identified by phage display |
| 09/04/2003 | WO2001092299A3 Adenovirus particles with mutagenized fiber proteins |
| 09/04/2003 | US20030166915 Retrovirus from the HIV group and its use |
| 09/04/2003 | US20030166832 Methods and compositions for impairing multiplication of HIV-1 |
| 09/04/2003 | US20030166286 Chimeric adenoviral fiber protein and methods of using same |
| 09/04/2003 | US20030166285 Methods and compositions for genetically modifying primate bone marrow cells |
| 09/04/2003 | US20030166267 Method for improving genetic stability of foreign insert nucleotide sequence in recombinant single-stranded RNA virus |
| 09/04/2003 | US20030166254 Moving promoter distal gene toward a wild-type 3' gene; gene mapping, genetic engineering; an attenuated virus useful for a vaccine |
| 09/04/2003 | US20030166253 A simple and efficient method of producing mammalian reovirus is developed using HEK 293 cells. The method provides for fast production of reovirus in high yield. Furthermore, this method provides for a simpler purification procedure of the |
| 09/04/2003 | US20030166252 Paramyxovirus-derived RNP |
| 09/04/2003 | US20030166251 High efficiency retroviral vector which contains genetically engineered cellular non-coding sequence harboring splicing acceptor |
| 09/04/2003 | US20030166240 DNA & protein binding miniature proteins |
| 09/04/2003 | US20030165877 Genetically engineered expression vector, phagemid or pseudovirions which transforms bacteria via synthetic cell wall membrane protein; gene transfer; gene therapy |
| 09/04/2003 | US20030165817 Diagnostic assay |
| 09/04/2003 | US20030165814 Screening for sensitivity to mystery swine disease virus infection by transfecting cells with CD antigens; animal husbandry |
| 09/04/2003 | US20030165540 Sentinel virus II |
| 09/04/2003 | US20030165539 Chimeric vaccine against tick-borne encephalitis virus |
| 09/04/2003 | US20030165536 Veterinary medicine; vaccine containing mutant gene |
| 09/04/2003 | US20030165535 Gag protein genes; reduced sensitivity |
| 09/04/2003 | US20030165534 Modified DNA molecule, recombinant containing the same, and uses thereof |
| 09/04/2003 | US20030165520 Attenuated forms of bovine viral diarrhea virus |
| 09/04/2003 | US20030165477 Poxvirus with targeted infection specificity |
| 09/04/2003 | US20030165465 Treatment of neoplasms with viruses |
| 09/04/2003 | US20030165463 Enhanced system for construction of adenovirus vectors |
| 09/04/2003 | US20030165462 Deleted adenovirus vectors and methods of making and administering the same |
| 09/04/2003 | CA2743750A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from respiratory syncytial virus |
| 09/04/2003 | CA2477235A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 09/04/2003 | CA2477234A1 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 09/04/2003 | CA2477037A1 Recombinant negative strand virus rna expression systems and vaccines |
| 09/04/2003 | CA2459155A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 09/03/2003 | EP1340813A1 Process for producing viral rna polymerase |
| 09/03/2003 | EP1339746A2 Binding polypeptides for b lymphocyte stimulator protein (blys) |
| 09/03/2003 | EP1339737A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 09/03/2003 | EP1339736A2 Oncolytic virus |
| 09/03/2003 | EP0857210B1 Therapeutic antiangiogenic compositions and methods |
| 09/03/2003 | EP0841943B1 Avirulent herpetic viruses useful as tumoricidal agents and vaccines |
| 09/03/2003 | EP0833670B1 Vaccine against rotavirus infection comprising peptides of viral enterotoxin nsp4 |
| 09/03/2003 | EP0763116B1 Recombinant viruses, preparation and use thereof in gene therapy |
| 09/03/2003 | CN1440456A Sentinel virus Ôàí" |
| 09/03/2003 | CN1440423A Immunoadhesin for the prevention of rhinovirus infection |
| 09/03/2003 | CN1120238C Pure herpes virus recombined with visco-particle as basement and its use |
| 09/03/2003 | CN1119933C Insect control method with genetically engineered biopesticides |
| 09/02/2003 | US6613892 Continuously expressing an inserted heterologous gene while remaining latent |
| 09/02/2003 | US6613569 Inducible packaging cell lines for lentivirus vectors |
| 09/02/2003 | US6613557 Recombinant DNA molecules which encode viral protein; transfecting a host cell with the DNA molecules; used for diagnostic purposes or for incorporation in a vaccine |
| 09/02/2003 | US6613556 Infecting cells from a continuous epithelial or fibroblast cell line, free of contaminants, with a high titer growth strain of dengue virus; use in vaccine production |
| 09/02/2003 | US6613514 Evolving preferential protein; digest nuclelotide sequences substrate, join terminals, screen for preferential proteins, recover nucleotide sequences |